drj logo

"*" indicates required fields

Name*
Address*
Password*
I agree to the Terms of Service and Privacy Policy*
Yes, of course I want to receive emails from DRJ!
This field is for validation purposes and should be left unchanged.

Already have an account? Log in

drj logo

Welcome to DRJ

Already registered user? Please login here

Login Form

Register
Forgot password? Click here to reset

Create new account
(it's completely free). Subscribe

x
Skip to content
Disaster Recovery Journal
  • EN ESPAÑOL
  • SIGN IN
  • SUBSCRIBE
  • THE JOURNAL
    • Why Subscribe to DRJ
    • Digital Edition
    • Article Submission
    • DRJ Annual Resource Directories
    • Article Archives
    • Career Spotlight
  • EVENTS
    • DRJ Spring 2024
    • Other Industry Events
    • Schedule & Archive
    • Send Your Feedback
  • WEBINARS
    • Upcoming Webinars
    • On Demand
  • MENTOR PROGRAM
  • DRJ ACADEMY
    • DRJ Academy
    • Beginner’s Guide to BC
  • RESOURCES
    • New to Business Continuity?
    • White Papers
    • DR Rules and Regs
    • Planning Groups
    • Business Resilience Decoded
    • DRJ Glossary of Business Continuity Terms
    • Careers
  • ABOUT
    • Advertise with DRJ
    • DE&I
    • Board and Committees
      • Executive Council Members
      • Editorial Advisory Board
      • Career Development Committee
      • Glossary Committee
      • Rules and Regulations Committee
  • Podcast

AHF to Shame Gilead with Nationwide Protests on World AIDS Day

by DRJ Editorial Team | November 30, 2022 | | 0 comments

Three PROTESTS Set for Thurs., Dec 1st in Washington, DC, Miami and San Diego at Gilead Offices

Advocates target Gilead’s insatiable greed and its drug pricing and policies, including illegal restrictions the drug company places for certain pharmacies on access to 340B drug pricing for Gilead’s branded hepatitis C treatments

WASHINGTON–(BUSINESS WIRE)–On World AIDS Day, Thursday, December 1st, advocates and mobilizers affiliated with AIDS Healthcare Foundation (AHF), will host a series of three protests across the U.S. targeting drug maker Gilead Sciences over the Bay Area company’s avarice in its drug pricing and policies. The nationwide protests will take place the same morning on Thursday, December 1st in Washington, DC (9:00 a.m. EST), Miami, Florida (11:30 a.m. EST), and in San Diego/Oceanside, California (10:30 a.m. PST)

WHAT: World AIDS Day drug company PROTESTS target Gilead Sciences’ Greed

WHEN: Thursday, December 1, 2022

9:00 a.m. EST

WASHINGTON, D.C.

Gilead Sciences, 300 New Jersey Ave, NW, Suite 650, Washington, D.C. 20001

AHF DC Media Contacts:

Denys Nazarov, +1.323.219.1091 cell denys.nazarov@ahf.org
Lauren Hogan, +1.310.940.0802 cell lauren.hogan@ahf.org

11:30 a.m. EST

MIAMI, FL

Gilead Sciences, 5200 Blue Lagoon Drive, Suite 450, Miami, FL 33126

AHF MIA Media Contact: Imara Canady, +1.770.940.6555 cell imara.canady@ahf.org

10:30 a.m. PST

OCEANSIDE, CA

Gilead Sciences, 4010 Ocean Ranch Blvd., Oceanside, CA 92056

AHF CA Media Contact: Ged Kenslea, +1.323.791.5526 cell ged.kenslea@ahf.org

WHO: 50 -100 advocates at each location with signs reading “Stop Being Greedy” and, playing off the company’s logo with a few red letters scrawled over Gilead’s logo, signs made to read “Greed” and “Greediad.”

Advocates are protesting Gilead over its profound and tone-deaf greed with pricing and policies, particularly illegal restrictions the company placed earlier this year on access to 340B drug pricing for its branded hepatitis C treatments for certain pharmacies. Gilead is now one of over 15 major drug companies that have illegally placed such restrictions on its drugs.

According to a 340B Report article from March, Gilead became the 15th drug manufacturer to place unlawful restrictions on 340B contract pharmacy programs. Lawyers for the Health and Human Services Department (HHS) in both the Biden and Trump administrations have said these restrictions are clearly illegal, yet drug companies like Gilead continue to forge ahead with the lawbreaking in search of even greater profits.

Moreover, according to the 340B Report, Gilead is now refusing to offer the 340B discount price for HIV drugs to providers who use contract pharmacies. Earlier this year, Gilead suddenly, dramatically increased—and in some instances, doubled—the price that safety net providers pay for its medication, Descovy – a drug needed for both HIV treatment and HIV prevention.

Protesters at all three locations—Washington, DC, Miami and Oceanside, CA—will have repurposed Gilead’s logo on signs that instead now spell out “Greed.” They’ll also sport signs reading “Stop Being Greedy.” The protests will take place the same day, with the East Coast events kicking off at 9:30 a.m. EST in Washington, D.C. and 11:30 a.m. EST in Miami while the California protest will start at 10:30 a.m. PST. Some protests will feature theatrical elements and protesters in costume—some dressed as a $1 million dollar bill, with pigs’ heads and snouts, and dressed as burglars with money bags slung over their shoulders.

AHF’s World AIDS Day Gilead protests follow a weeklong, twice-daily series of protests in late October targeting Gilead, maker of most of the key and most effective HIV medications and Hepatitis C drugs, at its headquarters in Foster City, CA. AHF also previously protested Gilead’s greed and actions on four separate occasions during the spring and summer at the Bay Area drug maker’s headquarters.

The 340B drug pricing program is administered by the U.S. Health Resources & Services Administration (HRSA). It has helped provide low-cost medications and better health outcomes for millions of Americans through the nonprofit clinics and hospitals that serve them. Safety net providers like Ryan White providers, who serve patients living with HIV, have the right under the 340B statute to purchase drugs at a discounted price. In March, Gilead put profits before patients by unilaterally imposing unlawful conditions on when and how it will give discounts for certain Hepatitis C drugs

“Gilead continues to demonstrate insatiable greed and avarice, showing it really cares FAR more about money than saving people’s lives. On World AIDS Day, we vow to keep holding Gilead and CEO Daniel O’Day accountable, whenever and wherever we can,” said AHF President Michael Weinstein. “Drug company profiteering and the abuse of lifesaving programs like 340B and community pharmacies nationwide by Gilead and others simply must stop!”

AHF mobilizers and advocates will be also deploying social media in real time at many of these Gilead protests and will be using hashtags: #PeopleBeforeProfit – #GreedyGilead

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million individuals in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth, follow us @aidshealthcare or subscribe to our AHF podcast “AHFter Hours.”

Contacts

WASHINGTON, D.C.
AHF DC Media Contact:

Denys Nazarov, +1.323.219.1091 cell, denys.nazarov@ahf.org

MIAMI, FL
AHF MIA Media Contact:

Imara Canady, +1.770.940.6555 cell, imara.canady@ahf.org

OCEANSIDE, CA
AHF CA Media Contact:

Ged Kenslea, +1.323.791.5526 cell, ged.kenslea@ahf.org

Related Content

  1. Disaster Recovery Journal
    Veterans and Business Continuity, A Match Made for a Catastrophe
  2. Disaster Recovery Journal
    The Difference a Hurricane Can Make: The Change of Louisiana’s Emergency Preparedness Effort
  3. Disaster Recovery Journal
    Change or Perish! Business Continuity Management as an Operational Competitive Edge

Recent Posts

SAIC to Realign Organization to Optimize Strategic Pivots and Increase Organic Growth

December 11, 2023

Discover Financial Services Appoints Michael G. Rhodes Chief Executive Officer and President

December 11, 2023

Casey’s Announces Second Quarter Results

December 11, 2023

Edify Improves Worker Safety with the Domo Data Experience Platform

December 11, 2023

Digi International Enters into New Senior Secured Credit Facility

December 11, 2023

Ayar Labs Names Mark Wade CEO

December 11, 2023

Archives

  • December 2023 (375)
  • November 2023 (1174)
  • October 2023 (1345)
  • September 2023 (1090)
  • August 2023 (1202)
  • July 2023 (956)
  • June 2023 (1245)
  • May 2023 (1206)
  • April 2023 (1145)
  • March 2023 (1336)
  • February 2023 (1154)
  • January 2023 (1391)
  • December 2022 (1144)
  • November 2022 (1595)
  • October 2022 (1574)
  • September 2022 (1571)
  • August 2022 (1581)
  • July 2022 (1365)
  • June 2022 (1711)
  • May 2022 (1651)
  • April 2022 (1618)
  • March 2022 (1924)
  • February 2022 (1549)
  • January 2022 (1472)
  • December 2021 (1446)
  • November 2021 (1835)
  • October 2021 (1777)
  • September 2021 (1697)
  • August 2021 (1661)
  • July 2021 (1566)
  • June 2021 (1768)
  • May 2021 (1666)
  • April 2021 (1798)
  • March 2021 (1907)
  • February 2021 (1038)
  • January 2021 (554)
  • December 2020 (30)
  • November 2020 (35)
  • October 2020 (48)
  • September 2020 (57)
  • August 2020 (52)
  • July 2020 (40)
  • June 2020 (72)
  • May 2020 (46)
  • April 2020 (59)
  • March 2020 (46)
  • February 2020 (28)
  • January 2020 (36)
  • December 2019 (22)
  • November 2019 (11)
  • October 2019 (36)
  • September 2019 (44)
  • August 2019 (77)
  • July 2019 (117)
  • June 2019 (106)
  • May 2019 (49)
  • April 2019 (47)
  • March 2019 (24)
  • February 2019 (37)
  • January 2019 (12)
  • ARTICLES & NEWS

    • Business Continuity
    • Disaster Recovery
    • Crisis Management & Communications
    • Risk Management
    • Article Archives
    • Industry News

    THE JOURNAL

    • Digital Edition
    • Advertising & Media Kit
    • Submit an Article
    • Career Spotlight

    RESOURCES

    • White Papers
    • Rules & Regulations
    • FAQs
    • Glossary of Terms
    • Industry Groups
    • Business & Resource Directory
    • Business Resilience Decoded
    • Careers

    EVENTS

    • Fall 2023
    • Spring 2024

    WEBINARS

    • Watch Now
    • Upcoming

    CONTACT

    • Article Submission
    • Media Kit
    • Contact Us

    ABOUT DRJ

    Disaster Recovery Journal is the industry’s largest resource for business continuity, disaster recovery, crisis management, and risk management, reaching a global network of more than 138,000 professionals. Offering weekly webinars, the latest industry news, rules and regulations, podcasts, the industry’s only official mentoring program, a quarterly magazine, and two annual live conferences, DRJ is leading the way to keep professionals up-to-date and connected in an ever-changing world.

    LEARN MORE

    LINKEDIN AND TWITTER

    Disaster Recovery Journal is the leading publication/event covering business continuity/disaster recovery.

    Follow us for daily updates

    LinkedIn

    @drjournal

    Newsletter

    The Journal, right in your inbox.

    Be informed and stay connected by getting the latest in news, events, webinars and whitepapers on Business Continuity and Disaster Recovery.

    Subscribe Now
    Copyright 2023 Disater Recovery Journal
    • Terms of Use
    • Privacy Policy